These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16968581)

  • 1. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK.
    Guest JF; Clegg JP; Smith AF
    Curr Med Res Opin; 2006 Sep; 22(9):1777-85. PubMed ID: 16968581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK.
    Guest JF; Clegg JP; Davie AM; McCloskey E
    Curr Med Res Opin; 2005 May; 21(5):805-15. PubMed ID: 15969880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
    Wade AG; Toumi I; Hemels ME
    Curr Med Res Opin; 2005 Apr; 21(4):631-42. PubMed ID: 15899113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
    Gong L; Sun X; Qu J; Wang L; Zhang M; Zhang H; Wang L; Gu Y; Elion-Mboussa A; Roy L; Zhu B
    Clin Ther; 2012 Jun; 34(6):1259-1272.e1. PubMed ID: 22627057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales.
    Guest JF; Candy DC; Clegg JP; Edwards D; Helter MT; Dale AK; Fell J; Cosgrove M; Debelle G
    Curr Med Res Opin; 2007 Sep; 23(9):2213-25. PubMed ID: 17692152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK.
    Christie AH; Culbert P; Guest JF
    Pharmacoeconomics; 2002; 20(1):49-60. PubMed ID: 11817992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of nurse led intermediate care versus standard care for post-acute medical patients: cost minimisation analysis of data from a randomised controlled trial.
    Walsh B; Steiner A; Pickering RM; Ward-Basu J
    BMJ; 2005 Mar; 330(7493):699. PubMed ID: 15757959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].
    Endre L; Hidasi V
    Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK.
    Borghi J; Guest JF
    Eur Psychiatry; 2000 Sep; 15(6):378-87. PubMed ID: 11004733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis.
    Alexander M; Allegro S; Hicks A
    Adv Ther; 2000; 17(3):140-7. PubMed ID: 11183450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
    Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
    J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
    Lanier BQ; Gross RD; Marks BB; Cockrum PC; Juniper EF
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):641-8. PubMed ID: 11428736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.
    Collum LM; Fitzsimon S; Hillery M; Collum A; Power WJ; Pelikan Z; Jenson JB
    Doc Ophthalmol; 1992; 82(3):267-77. PubMed ID: 1303863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.
    Rivero-Arias O; Campbell H; Gray A; Fairbank J; Frost H; Wilson-MacDonald J
    BMJ; 2005 May; 330(7502):1239. PubMed ID: 15911536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
    Abelson MB; Gomes PJ; Pasquine T; Edwards MR; Gross RD; Robertson SM
    Allergy Asthma Proc; 2007; 28(4):427-33. PubMed ID: 17883910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.
    Guest JF; Hart WM; Cookson RF
    Pharmacoeconomics; 1998 Sep; 14(3):285-97. PubMed ID: 10186467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.